Develop novel and innovative small molecule therapeutics to treat (post-exposure therapeutic) infections by both filovirus family members (ebola viruses and marburg viruses)
Ended Definitive Contract Awarded Last action
- Contract number
- HDTRA118C0001
- Awardee
-
Microbiotix, Inc. UEI SCNKBDM341T1
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Obligated
- $2,554,224
Award facts
- Contract value 98% obligated
- $2,594,319.91 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Defense Threat Reduction Agency Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 92 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Worcester, MA 01605, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$40,096 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $450,209 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $102,457 | |
| Exercise an Option | $464,520 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $583,179 | |
| Exercise an Option | $280,540 | |
| Funding Only Action | $613,415 | |
| Original award | $100,000 |
Show all 11
About this award
This is a $2,594,319.91 federal contract awarded by the Defense Threat Reduction Agency (DTRA) to Microbiotix, Inc., a clinical-stage biopharmaceutical company. The contract is for the development of novel small molecule therapeutics to treat infections by Ebola and Marburg viruses. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a period of performance ending on December 14, 2020. Microbiotix has subcontracted with the Albert Einstein College of Medicine and the Geneva Foundation to support the research and development work. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HDTRA118C0001?
HDTRA118C0001 was awarded to Microbiotix, Inc. by Defense Contract Management Agency (Department of Defense) on December 15, 2017.
How much is contract HDTRA118C0001 worth?
The government has obligated $2,554,224 on HDTRA118C0001. Its current value, with exercised options, is $2,594,320.
Which agency awarded contract HDTRA118C0001?
Defense Contract Management Agency (Department of Defense) awarded HDTRA118C0001, with funding from Defense Threat Reduction Agency (Department of Defense).
Was contract HDTRA118C0001 competed?
The extent of competition for HDTRA118C0001 was full and open competition. The government received 92 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award